Evidence map›Paper›PMID 20826623›Full record

Trial reportThe American journal of clinical nutrition2010

Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.

Jeremy D Furtado, Hannia Campos, Anne E Sumner, Lawrence J Appel, Vincent J Carey, Frank M Sacks

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00051350 (Macronutrients and Cardiovascular Risk), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00051350 nacompletednot on this map

Macronutrients and Cardiovascular Risk

TypeinterventionalSponsorJohns Hopkins UniversityRan2002 to 2008Enrolled164ConditionsCardiovascular Diseases, Heart Diseases, Atherosclerosis, HypertensionArmsCARB
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Best practice & research. Clinical endocrinology & metabolism · 2014
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jeremy D FurtadoHarvard School of Public Health, Boston, MA, USA. jfurtado@hsph.harvard.edu
Hannia Campos
Anne E Sumner
Lawrence J Appel
Vincent J Carey
Frank M Sacks
Johns Hopkins University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USHarvard University · US

Funding

Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1985 to 2008
$48.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Heart Disease Risk Factors In African AmericansZIADK047023 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SUMNER, ANNE · 2009 to 2025
$16.3M
Macronutrients and Cardiovascular RiskR01HL067098 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI APPEL, LAWRENCE JOHN · 2002 to 2006
$6.8M
Renal blood flow, vascular stiffness, and the DASH dietK24DK063214 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI CONLIN, PAUL R · 2003 to 2012
$1.7M
Impact of Lifestyle Changes on Inflammation &HemostasisK23HL068712 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ERLINGER, THOMAS PHILIP · 2002 to 2005
$526k
NCRR NIH HHS RR02635NHLBI NIH HHS HL67098NHLBI NIH HHS HL68712NIDDK NIH HHS DK63214NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

backgroundBlacks have lower average triglyceride and LDL cholesterol concentrations than do whites but higher rates of coronary heart disease. Apolipoprotein (apo) C-III in VLDL and LDL stimulates atherogenic processes in vascular cells. In blacks, the concentration of lipoproteins with apo C-III is unknown, and the response to dietary strategies that lower triglyceride and apo C-III has not been investigated

objectiveWe compared the concentration of and dietary effects on apo C-III-containing lipoproteins in blacks and whites.

designIn a randomized, 3-period feeding study [OmniHeart (Optimal Macronutrient Intake Trial to Prevent Heart Disease)], we measured lipoprotein concentrations in 89 blacks and 73 whites who consumed self-selected diets (baseline) and after 3 healthful diets emphasizing carbohydrate, unsaturated fat, or protein. Participants had prehypertension or hypertension, and 79% were overweight or obese.

resultsWhile consuming self-selected diets, blacks had lower apo C-III in total plasma, VLDL, and LDL than did whites. Unsaturated fat and protein diets lowered plasma apo C-III (16% and 18%, respectively) and triglyceride (12% and 21%, respectively) in whites but not in blacks, reducing racial differences. Most important, blacks had a lower concentration of atherogenic LDL with apo C-III at baseline and after study diets (34-41% lower, P < 0.02). The molar ratio of apo E to apo B was higher in blacks than in whites in total plasma and LDL at baseline and after the study diets.

conclusionsBlacks have lower concentrations of atherogenic lipoproteins that contain apo C-III than do whites when consuming diverse diets and an attenuated dietary response of triglyceride and apo C-III. Dietary efforts to lower triglyceride and apo C-III may be more effective in whites than in blacks. The OmniHeart Trial was registered at www.clinicaltrials.gov as NCT00051350.

Indexed as

DietAdultAgedApolipoprotein C-IIIApolipoproteinsBlack PeopleCholesterol, HDLCoronary DiseaseFemaleHeart DiseasesHumansHypertensionLipoproteinsLipoproteins, LDLLipoproteins, VLDLMaleApolipoprotein C-IIIApolipoproteinsCholesterol, HDLLipoproteinsLipoproteins, LDLLipoproteins, VLDLTriglycerides

Identifiers

PMID20826623
PMCPMC2937582
OpenAlexW2107664827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.